Abstract
Fluoxetine treatment for depression in AD did not differ significantly from treatment with placebo. Our study also confirms the presence of a placebo effect in the treatment of depression in AD.
Keywords
FluoxetinePlaceboClinical Global ImpressionDepression (economics)PsychologyHamilton Rating Scale for DepressionPsychiatryInternal medicineRating scaleAnxietyMoodMedicineSerotoninMajor depressive disorder
Affiliated Institutions
Related Publications
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder
In this 8-week double-blind multicenter trial, we evaluated the efficacy and safety of 2 fixed doses of agomelatine in patients with moderate to severe major depressive disorder...
The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms
Abstract This paper describes the rationale and methods entailed in developing the Inventory of Depressive Symptomatology (IDS) in both clinician‐rated (IDS‐C) and self‐reported...
Treatment-resistant depression in the age of serotonin: evolving strategies
Serotonin specific reuptake inhibitor antidepressants (SSRIs) have become the de facto first line treatment in pharmacotherapy of major depression. Albeit SSRIs have the advanta...
Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder
A six- to eight-week double-blind placebo-controlled trial of the potent and selective serotonin reuptake inhibitor fluvoxamine was conducted in 42 patients with primary obsessi...
Neuroendocrine Response to L-5-Hydroxytryptophan Challenge in Prepubertal Major Depression
The neuroendocrine response to L-5-hydroxytryptophan was compared in 37 prepubertal children who met the Research Diagnostic Criteria for major depressive disorder with that in ...
Publication Info
- Year
- 2001
- Type
- article
- Volume
- 13
- Issue
- 2
- Pages
- 233-240
- Citations
- 140
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
140
OpenAlex
Cite This
Gustavo Petracca,
Erán Chemerinski,
Sergio Starkstein
(2001).
A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer’s Disease.
International Psychogeriatrics
, 13
(2)
, 233-240.
https://doi.org/10.1017/s104161020100761x
Identifiers
- DOI
- 10.1017/s104161020100761x